What is CVE-2022-26041?

CVE-2022-26041 is a medium-severity vulnerability in Generex Rccmd, classified under Path Traversal. CVSS score: 6.5/10. Published 2022-06-13.

How severe is CVE-2022-26041?

Medium severity. CVSS v3 base score is 6.5 out of 10.

Path Traversal in Generex Rccmd

CVE-2022-26041

Directory traversal vulnerability in RCCMD 4.26 and earlier allows a remote authenticated attacker with an administrative privilege to read or alter an arbitrary file on the server via unspecified vectors.

Vulnerability class: Path Traversal (Directory Traversal)

EPSS: 0.014 (70.6th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:N.

Affected products

Generex Rccmd
Generex Systems Computervertriebsgesellschaft Mbh Rccmd — versions 4.26 and earlier

Weakness classification (CWE)

CWE-22 — Path Traversal

References

vultures@jpcert.or.jp (x_refsource_MISC, Vendor Advisory)
vultures@jpcert.or.jp (Third Party Advisory, x_refsource_MISC)

Frequently asked questions

What is CVE-2022-26041?: CVE-2022-26041 is a medium-severity vulnerability in Generex Rccmd, classified under Path Traversal. CVSS score: 6.5/10. Published 2022-06-13.
How severe is CVE-2022-26041?: Medium severity. CVSS v3 base score is 6.5 out of 10.